Breaking News
February 20, 2018 - Lab-grown cerebellar cells may help explain how ASD develops at molecular level
February 20, 2018 - New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
February 20, 2018 - Do You Really Need My Signature on That?
February 20, 2018 - HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection
February 20, 2018 - Diabetes does not increase work-loss years due to early retirement
February 20, 2018 - Researchers aim to find out how PTSD affects decisions of police
February 20, 2018 - UH Cleveland Medical Center explores novel treatments for uterine fibroids
February 20, 2018 - Flu Vax Efficacy 25% Against Predominant H3N2 Strain So Far
February 20, 2018 - HIV screening most optimal at 25 years of age if no risk factors
February 20, 2018 - Loyola Medicine primary care physician offers advice to minimize risk of flu
February 20, 2018 - Safe sleep recommendations for parents that may help reduce child’s risk of SUID
February 20, 2018 - Why Do So Few Docs Have Buprenorphine Waivers?
February 20, 2018 - Low levels of alcohol good for the brain
February 20, 2018 - Experimental treatment improves invisible symptoms of a man with spinal cord injury
February 20, 2018 - Myriad’s EndoPredict offers better prediction of breast cancer recurrence, analysis shows
February 20, 2018 - Researchers identify fifteen genes that determine our facial features
February 20, 2018 - Morning Break: New Health IT Player; Luxturna No Bargain; Nuclear Freakout
February 20, 2018 - How does it compare? Hospice care at home, at assisted living facility, at nursing home
February 19, 2018 - Scientists develop water-soluble warped nanographene for bioimaging
February 19, 2018 - It’s Not Your Imagination: You’re Hungrier After Losing Weight
February 19, 2018 - Antihypertensive Use At Delivery Rising in Preeclampsia
February 19, 2018 - A centuries-old math equation used to solve a modern-day genetics challenge
February 19, 2018 - Liquid biopsies could be used as new predictive marker for metastatic TNBC
February 19, 2018 - Russian researchers develop new multi-layered biodegradable scaffolds
February 19, 2018 - Are ‘Vaccine Skeptics’ Responsible for Flu Deaths?
February 19, 2018 - Hidden genetic effects behind immune diseases may be missed, study suggests
February 19, 2018 - Emergency nurses experience regular verbal and physical abuse
February 19, 2018 - Study sheds light on biology that guides behavior across different stages of life
February 19, 2018 - Morning Break: Transgender Breast Feeding; Brazilian ‘Pro-Vaxxers’; Post-Stroke Exercise
February 19, 2018 - Meningitis vaccination strategy in Africa found to be effective, economical
February 19, 2018 - Researchers uncover how excess calcium may influence development of Parkinson’s disease
February 19, 2018 - Psoriasis drug also effective at reducing aortic inflammation
February 19, 2018 - Excess emissions can make serious contributions to air pollution, study shows
February 19, 2018 - Researchers reveal potential biological roots behind individuality
February 19, 2018 - Diabetes Drugs Differ on HF; School-Based Obesity Program Flop; Plaque Type in ACS
February 19, 2018 - Surgical infections linked to drug-resistant bugs, study suggests
February 19, 2018 - Poor awareness may hinder a child’s early dental care
February 19, 2018 - Research finds rising trend in incidence of merkel cell carcinoma
February 19, 2018 - Researchers uncover Ras protein’s role in uncontrolled cancer growth
February 19, 2018 - FDA Approves Apalutamide (Erleada) to Help Curb a Tough-to-Treat Prostate Cancer
February 19, 2018 - Educational Tool Boosts Cervical Length Screening
February 19, 2018 - Spider’s web inspires removable implant that may control type 1 diabetes
February 19, 2018 - Scientists develop fluorescent probe to identify cancer stem cells
February 19, 2018 - University Hospital of Santiago de Compostela participates in large pancreatic cancer study
February 19, 2018 - New blood test shows promise to revolutionize diagnosis of tick-borne diseases
February 19, 2018 - Report: Use, Not Price, Drives State Health Costs
February 19, 2018 - Emergency services crews often unprepared for diabetic crises
February 19, 2018 - Scientists in Sweden create DNA nanowires that offer hope for treatment of diseases
February 19, 2018 - ID Break: Clean Hands, Fewer Abx; $11 Million HIV Cure?; MenB Vax for Kids
February 19, 2018 - Patient exposure to X-rays depends on how dentists are paid
February 19, 2018 - Study reveals parents’ views toward children’s tanning bed use
February 19, 2018 - Shot may help reduce risk of shingles
February 19, 2018 - FDA approves first treatment to reduce risk of NSCLC progression
February 19, 2018 - FDA Expands Approval of Imfinzi (durvalumab) to Reduce the Risk of Non-Small Cell Lung Cancer Progressing
February 19, 2018 - D.C. Week: Congress Passes Spending Bill
February 19, 2018 - Heart-muscle patches made with human cells improve heart attack recovery
February 19, 2018 - FDA Approves First Blood Test to Detect Concussions
February 19, 2018 - Survival Bump in Bladder Cancer with Keytruda
February 18, 2018 - Scientists describe the mechanism of heart regeneration in the zebrafish
February 18, 2018 - Scientists uncover the structure of microtubule motor proteins
February 18, 2018 - Light-activated cancer drugs without toxic side effects are closer to becoming reality
February 18, 2018 - Pioneering research could provide novel insight into how genomic information is read
February 18, 2018 - Pearls From: David Putrino, PhD
February 18, 2018 - Researchers uncover how cancer stem cells drive triple-negative breast cancer
February 18, 2018 - Morning Break: Anti-Anti-Vaxxers; Private Piercings Prohibited; A Case for Pelvic Massage
February 18, 2018 - Lower-dose radiation effective, safe for HPV+ head and neck cancer after induction chemo
February 18, 2018 - Specialist residential service for adults with autism opens in Swansea
February 18, 2018 - FDA Moves to Limit Loperamide Doses per Package
February 18, 2018 - Alcohol use disorder – Genetics Home Reference
February 18, 2018 - Autism might be better detected using new two-minute questionnaire
February 18, 2018 - Hand hygiene-intervention practices may reduce risk of infection among nursing home patients
February 18, 2018 - Researchers develop most sophisticated mini-livers to date
February 18, 2018 - Obamacare Helped More Young Women Get Prenatal Care: Study
February 18, 2018 - School-Based Program Fails to Dent Kids’ Obesity
February 18, 2018 - Research compares neural activity in children with and without autism spectrum disorder
February 18, 2018 - Poor fitness levels increase the risk dementia, concludes study
February 18, 2018 - Risk Score May Reveal if Kids are Victims of Ill-Treatment
February 18, 2018 - Adding Folic Acid to Corn Masa Flour May Prevent Birth Defects
February 18, 2018 - Acute treatment suppresses posttraumatic arthritis in ankle injury
February 18, 2018 - A Role for Budesonide in Autoimmune Hepatitis?
New learn about goals to check protection and efficacy of antiplatelet drug in fighting blood clots

New learn about goals to check protection and efficacy of antiplatelet drug in fighting blood clots

image_pdfDownload PDFimage_print

A brand new medical learn about is beginning on the German Centre for Cardiovascular Analysis (DZHK) with an leading edge and extremely explicit blood thinner. Headed through the DZHK Munich website, the scientists need to verify how safely and successfully this compound, which handiest acts in the community, can save you blood clots in sufferers with a coronary center illness being handled with a cardiac catheter.

The coronary vessels are blocked in coronary center illness. If physicians dilate the vessels with a catheter, the deposits (plaques) can tear and injury the partitions of the blood vessels. Such small damages are a chance issue for circulatory issues and center assaults, as platelets can adhere to those websites and clots can shape. Sufferers due to this fact obtain blood thinning medication that save you platelet accumulation all over the process. The downside of the medication used up to now is that in addition they build up the chance of probably existence‑threatening bleedings, as a result of they inhibit a central step of haemostasis, or platelet accumulation, in all the frame. The aim of the DZHK learn about, which is headed through the German Center Centre Munich, is to analyze whether or not the brand new antiplatelet drug Revacept reduces the formation of blood clots all over cardiac catheterization with out expanding the bleeding chance. Compared to standard blood thinners, Revacept handiest binds to the broken websites within the vessel and shields them in order that no platelets can gather there. “Revacept is sort of a plaster that seals the lesion in a centered method”, exemplifies PD Dr. Stefanie Schüpke of the German Center Centre Munich.

From the laboratory to the affected person

Years of extensive fundamental analysis, by which scientists at LMU Munich and the Technical College Munich researched how platelets adhere to broken vessel websites, preceded the advance of Revacept. “It was once an important to focus on constructions that distinguish between wholesome and atherosclerotic vessels”, explains Prof. Adnan Kastrati of the German Center Centre Munich, probably the most leader investigators. Because of this, the scientists targeted at the adhesion of platelets to the collagen that handiest protrudes into the blood circulation the place vessel partitions are broken. The agent Revacept was once created in keeping with their findings. It binds to the collagen of the broken websites in a centered method and thus prevents the adhesion of platelets. “Revacept is an instance of a hit translational analysis, by which the findings from fundamental analysis result in the advance of leading edge remedies”, clarifies Prof. Thomas Eschenhagen, the consultant of the DZHK Board of Administrators.

For the primary time in sufferers with coronary center illness

Revacept was once additional evolved right into a drug to be used in people through the biotech corporate advanceCOR, a spin-off of the Technical College Munich. A prior learn about with wholesome volunteers has already confirmed that Revacept is secure and smartly tolerated. Additionally, a medical trial is already being performed investigating Revacept in stroke sufferers. Within the upcoming learn about, 332 sufferers with a coronary center illness for whom a catheterization is deliberate can be tested. Some sufferers can be handled with Revacept along with the standard drugs. Right through the learn about, bleeding chance can be monitored and a marker within the blood can be used to analyze whether or not Revacept sufficiently prevents injury of the guts muscle. In general, six DZHK websites are taking part within the learn about, which is co-financed through the producer, advanceCOR GmbH in Martinsried.


Posted in: Drug Trial Information | Clinical Process Information | Clinical Situation Information

Tags: Blood, Blood Vessels, Catheter, Scientific Trial, Collagen, Compound, Coronary Center Illness, Medication, Center, Center Illness, Laboratory, Muscle, Platelets, Stroke

Tagged with:

About author

Related Articles